Home > M&A deals 2020 > Assertio Therapeutics, Inc. merges with Zyla Life Sciences
Merger · Life Science · March 2020

Assertio Therapeutics, Inc. merges with Zyla Life Sciences

On March 16, 2020, Assertio Therapeutics, Inc. merged with Zyla Life Sciences, a life science company in Pennsylvania, United States.

Deal at a glance

AnnouncedMarch 16, 2020 TypeMerger TargetZyla Life Sciences Buyer Assertio Therapeutics, Inc. SectorLife Science LocationPennsylvania, United States ValueNot disclosed

Target company

Zyla Life Sciences
Pennsylvania, United States
Life Sciencesector
2012founded
Activestatus
View the company profile →

Buyer

Assertio Therapeutics, Inc.
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in United States
1deals, all time
1in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Zyla Life Sciences?Assertio Therapeutics, Inc. merged with Zyla Life Sciences on March 16, 2020.

What type of deal was it?It was a merger in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).